Cognex Corporation (CGNX)
Official siteTECHNOLOGY • SCIENTIFIC & TECHNICAL INSTRUMENTS • NASDAQ
Market Cap: $8.42B
Last updated: Nov 17, 2026 at 11:04 AM ET
Cognex Corporation (CGNX) Financials: Revenue, Profit and Cash Flow
Cognex reported revenue of $994.36M for the fiscal year ended Dec 31, 2025, up 8.7% from the year before. That year, net income was $114.44M with a net margin of 11.5%, operating cash flow was $245.51M and free cash flow was $236.77M. The quarter ended Sep 30, 2026 had revenue of $313.39M and net income of $84.82M.
Revenue and Margins
The operating margin was 16.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $529.51M, a compound annual rate of 7.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $994.36M | +8.7% | 66.9% | 16.3% | 11.5% |
| Dec 2024 | $914.51M | +9.2% | 68.4% | 12.6% | 11.6% |
| Dec 2023 | $837.55M | -16.8% | 71.8% | 15.6% | 13.5% |
| Dec 2022 | $1.01B | -3.0% | 71.8% | 24.5% | 21.4% |
| Dec 2021 | $1.04B | +27.9% | 73.3% | 30.4% | 27.0% |
| Dec 2020 | $811.02M | +11.8% | 74.5% | 21.0% | 21.7% |
| Dec 2019 | $725.63M | -10.0% | 73.8% | 19.7% | 28.1% |
| Dec 2018 | $806.34M | +5.3% | 74.4% | 27.4% | 27.2% |
| Dec 2017 | $766.08M | +44.7% | 75.6% | 33.8% | 23.1% |
| Dec 2016 | $529.51M | N/A | 75.2% | 29.1% | 27.1% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 7.8% from the year before. In the quarter ended Sep 2026, net income rose 380.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $994.36M | $914.51M | $837.55M | $1.01B | $1.04B | $811.02M | $725.63M | $806.34M | $766.08M | $529.51M |
| Cost of revenue | $328.97M | $288.72M | $236.31M | $284.19M | $277.27M | $206.42M | $189.75M | $206.05M | $187.29M | $131.07M |
| Gross profit | $665.39M | $625.79M | $601.24M | $721.90M | $759.83M | $604.60M | $535.87M | $600.29M | $578.79M | $398.44M |
| Research and development | $138.97M | $139.81M | $139.40M | $141.13M | $135.37M | $130.98M | $119.43M | $116.44M | $99.20M | $78.27M |
| Operating income | $162.57M | $115.06M | $130.70M | $246.23M | $315.10M | $170.53M | $142.60M | $221.14M | $258.86M | $154.07M |
| Net income | $114.44M | $106.17M | $113.23M | $215.53M | $279.88M | $176.19M | $203.87M | $219.27M | $176.71M | $143.69M |
| EBITDA | $195.91M | $150.51M | $144.88M | $268.57M | $337.41M | $201.69M | $167.59M | $241.52M | $274.12M | $170.49M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $313.39M | $291.26M | $268.44M | $252.34M | $276.89M | $249.09M | $216.04M | $229.68M | $234.74M | $239.29M | $210.80M | $196.67M |
| Gross profit | $221.74M | $205.77M | $190.94M | $165.90M | $187.29M | $167.88M | $144.32M | $157.86M | $159.40M | $166.60M | $141.94M | $135.04M |
| Operating income | $100.82M | $85.52M | $59.87M | $35.28M | $57.77M | $43.43M | $26.09M | $30.84M | $31.56M | $38.46M | $14.20M | $12.73M |
| Net income | $84.82M | $72.76M | $51.70M | $32.66M | $17.66M | $40.51M | $23.60M | $28.35M | $29.59M | $36.21M | $12.02M | $11.23M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $11.72M by $251.21M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.02B | $1.99B | $2.02B | $1.96B | $2.00B | $1.80B | $1.89B | $1.29B | $1.29B | $1.04B |
| Current assets | $697.25M | $613.37M | $679.00M | $717.70M | $639.80M | $601.69M | $607.23M | $780.33M | $629.99M | $526.34M |
| Cash and equivalents | $262.93M | $186.09M | $202.66M | $181.37M | $186.16M | $269.07M | $171.43M | $108.21M | $106.58M | $79.64M |
| Total liabilities | $524.65M | $475.35M | $513.06M | $519.75M | $573.57M | $538.50M | $530.23M | $154.40M | $192.08M | $76.00M |
| Short-term debt | $11.72M | $8.85M | $9.62M | $8.45M | $7.79M | $8.11M | $5.65M | $5.06M | $16.68M | $31.98M |
| Shareholder equity | $1.49B | $1.52B | $1.50B | $1.44B | $1.43B | $1.26B | $1.36B | $1.14B | $1.10B | $962.60M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.28B | $2.18B | $2.01B | $2.02B | $2.00B | $2.00B | $1.93B | $1.99B | $2.06B | $2.00B | $2.01B | $2.02B |
| Total liabilities | $554.98M | $549.10M | $526.65M | $524.65M | $513.11M | $497.48M | $486.88M | $475.35M | $496.22M | $497.35M | $524.04M | $513.06M |
| Cash and equivalents | $694.70M | $302.52M | $237.34M | $262.93M | $245.90M | $179.31M | $143.74M | $186.09M | $197.07M | $176.63M | $138.86M | $202.66M |
| Shareholder equity | $1.72B | $1.63B | $1.48B | $1.49B | $1.49B | $1.51B | $1.45B | $1.52B | $1.57B | $1.51B | $1.49B | $1.50B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 96.4% of operating cash flow. Dividends and share repurchases together came to 87.1% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $245.51M | $149.08M | $112.92M | $243.41M | $314.06M | $242.40M | $253.31M | $223.45M | $224.32M | $182.08M |
| Capital expenditures | $8.74M | $15.04M | $23.08M | $19.67M | $15.46M | $13.30M | $21.75M | $37.09M | $28.75M | $12.82M |
| Free cash flow | $236.77M | $134.04M | $89.84M | $223.74M | $298.61M | $229.10M | $231.57M | $186.36M | $195.57M | $169.26M |
| Dividends paid | $54.63M | $52.33M | $49.08M | $45.92M | $43.26M | $390.51M | $35.12M | $31.86M | $29.04M | $25.21M |
| Share repurchases | $151.62M | $67.08M | $79.79M | $204.31M | $161.65M | $51.04M | $61.69M | $203.82M | $123.72M | $47.15M |
| Investing cash flow | $28.02M | -$38.97M | $32.27M | -$4.45M | -$252.54M | $169.44M | -$157.34M | -$10.83M | -$105.56M | -$121.83M |
| Financing cash flow | -$206.69M | -$118.42M | -$125.61M | -$240.37M | -$141.62M | -$316.87M | -$32.23M | -$209.90M | -$100.12M | -$29.23M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $106.42M | $69.15M | $45.09M | $74.90M | $87.48M | $42.63M | $40.50M | $51.40M | $56.27M | $27.76M | $13.64M | $14.49M |
| Capital expenditures | $2.64M | $1.53M | $2.76M | $2.60M | $1.45M | $2.19M | $2.50M | $2.07M | $4.40M | $4.51M | $4.06M | $7.01M |
| Free cash flow | $103.78M | $67.62M | $42.34M | $72.31M | $86.03M | $40.43M | $38.00M | $49.33M | $51.87M | $23.25M | $9.58M | $7.48M |
Frequently Asked Questions About CGNX
What is Cognex's annual revenue?
Cognex reported revenue of $994.36M for the fiscal year ended Dec 31, 2025.
How fast is Cognex's revenue growing?
Revenue was up 8.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.4%.
Is Cognex profitable?
Yes. Cognex reported net income of $114.44M for the fiscal year ended Dec 31, 2025, with a net margin of 11.5%.
How much free cash flow does CGNX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $245.51M minus capital expenditures of $8.74M produced free cash flow of $236.77M.
How much debt does Cognex have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $11.72M and cash and equivalents of $262.93M.
CGNX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors